Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Global Regulatory Systems01:28

Global Regulatory Systems

69
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
69
Quality Assurance01:19

Quality Assurance

193
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
193
Drug Control Governance: Regulatory Bodies and Their Impact01:03

Drug Control Governance: Regulatory Bodies and Their Impact

234
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
234
Data Validation01:15

Data Validation

224
Method validation is a crucial process in analytical chemistry designed to confirm that a given method consistently produces reliable and high-quality results. This process is essential when a method is applied to different sample matrices or when procedural modifications are made, ensuring that the results meet acceptable standards across various applications.
Key parameters for method validation include:
224
Actuarial Approach01:20

Actuarial Approach

121
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
121
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

164
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
164

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Assessing corporate transition plans using a production asset-based planning approach.

Nature communications·2026
Same author

Temporary mitigation off-ramps could help manage decarbonization headwinds.

Nature communications·2024
Same author

Minimizing the impacts of the ammonia economy on the nitrogen cycle and climate.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same author

Nosocomial or not? A combined epidemiological and genomic investigation to understand hospital-acquired COVID-19 infection on an elderly care ward.

Infection prevention in practice·2021
Same author

Exploring the Cognitive Foundations of Managerial (Climate) Change Decisions.

Journal of business ethics : JBE·2021
Same author

Development and implementation of a clinical information system-based protocol to improve nurse satisfaction of end-of-life care in a single intensive care unit.

Australian critical care : official journal of the Confederation of Australian Critical Care Nurses·2021
Same journal

The BRCA1-A complex restricts replication fork reversal-dependent DNA repair in ATM deficient cells.

Nature communications·2026
Same journal

Signaling downstream of tumor-stroma interaction regulates mucinous colorectal adenocarcinoma apicobasal polarity.

Nature communications·2026
Same journal

Click-polymerized polyenamine membranes for efficient lithium extraction.

Nature communications·2026
Same journal

Joint trajectories of brain atrophy, white matter hyperintensities and cognition quantify brain maintenance.

Nature communications·2026
Same journal

Proton shuttling at electrochemical interfaces under alkaline hydrogen evolution.

Nature communications·2026
Same journal

metilene<sup>3</sup>: identifying DMRs across multiple conditions with auto-classification.

Nature communications·2026
See all related articles

Related Experiment Video

Updated: Sep 2, 2025

Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System
08:59

Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System

Published on: May 22, 2020

5.6K

Measuring corporate Paris Compliance using a strict science-based approach.

S Rekker1, M C Ives2, B Wade3

  • 1UQ Business School, University of Queensland, Brisbane, QLD, Australia. s.rekker@uq.edu.au.

Nature Communications
|August 10, 2022
PubMed
Summary
This summary is machine-generated.

Companies must align greenhouse gas emissions with Paris Agreement goals. A new method assesses compliance, finding most major companies are not yet aligned, risking significant investment exposure.

More Related Videos

Using Capillary Electrophoresis to Quantify Organic Acids from Plant Tissue: A Test Case Examining Coffea arabica Seeds
10:13

Using Capillary Electrophoresis to Quantify Organic Acids from Plant Tissue: A Test Case Examining Coffea arabica Seeds

Published on: November 12, 2016

9.9K
Implementation of Portable Emissions Measurement Systems PEMS for the Real-driving Emissions RDE Regulation in Europe
09:34

Implementation of Portable Emissions Measurement Systems PEMS for the Real-driving Emissions RDE Regulation in Europe

Published on: December 4, 2016

28.2K

Related Experiment Videos

Last Updated: Sep 2, 2025

Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System
08:59

Measuring Sub-23 Nanometer Real Driving Particle Number Emissions Using the Portable DownToTen Sampling System

Published on: May 22, 2020

5.6K
Using Capillary Electrophoresis to Quantify Organic Acids from Plant Tissue: A Test Case Examining Coffea arabica Seeds
10:13

Using Capillary Electrophoresis to Quantify Organic Acids from Plant Tissue: A Test Case Examining Coffea arabica Seeds

Published on: November 12, 2016

9.9K
Implementation of Portable Emissions Measurement Systems PEMS for the Real-driving Emissions RDE Regulation in Europe
09:34

Implementation of Portable Emissions Measurement Systems PEMS for the Real-driving Emissions RDE Regulation in Europe

Published on: December 4, 2016

28.2K

Area of Science:

  • Climate Science
  • Environmental Policy
  • Corporate Sustainability

Background:

  • The Paris Agreement mandates global efforts to limit warming well-below 2 degrees Celsius.
  • Corporate emission reduction strategies are crucial for achieving these climate targets.
  • Assessing corporate alignment with Paris goals requires standardized methodologies.

Purpose of the Study:

  • To establish strict criteria for classifying corporate emissions reduction methodologies as Paris-Compliant.
  • To develop operational requirements for companies to declare and track their Paris-Compliant Pathways.
  • To evaluate the current compliance status of high-emission companies within the electric utility and cement sectors.

Main Methods:

  • Defined strict conditions for Paris-Compliant emissions allocation, including a common base year and alignment with decarbonisation pathways.
  • Proposed four operationalisation requirements for calculating carbon budgets and re-alignment pathways.
  • Applied the developed methodology to ten electric utility and ten cement companies.

Main Results:

  • All but one analyzed company failed to meet the proposed Paris-Compliant criteria.
  • Delayed action significantly increases the required decarbonisation rate for non-compliant companies.
  • Billions of investment dollars are exposed to transition risk due to non-compliance.

Conclusions:

  • The proposed framework provides a robust method for assessing corporate Paris Agreement compliance.
  • Accurate tracking of corporate progress is essential for meeting global carbon budgets.
  • Companies and stakeholders must act decisively to align with Paris goals and mitigate transition risks.